PROTECT-V Clinical Trial (@protect_cctu) 's Twitter Profile
PROTECT-V Clinical Trial

@protect_cctu

PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V) [email protected]

ID: 1253281498284855301

linkhttps://www.camcovidtrials.net/trials/PROTECT calendar_today23-04-2020 11:16:22

74 Tweet

217 Followers

193 Following

DCHFT Research (@dchft_research) 's Twitter Profile Photo

The Renal team have welcomed 4 new participants to the PROTECT-V Clinical Trial study. Thank you for being so keen to take part and to DCHFT_Pharmacy for processing our prescriptions speedily. Looking forward to welcoming more in the coming weeks! #TeamDCH #TrialBlazers Dorset County Hospital NHS Foundation Trust #Covid

DCHFT Research (@dchft_research) 's Twitter Profile Photo

Another participant has joined the PROTECT-V Clinical Trial trial this morning - thats three in the last week! Thanks so much to our renal patients Dorset County Hospital NHS Foundation Trust for being so kind with your time, particularly in this heat! #TeamDCH #COVID19 #niclosamide #bepartofresearch #ResearchActiveTrust

Professor Alex Richter (@alexrichter3) 's Twitter Profile Photo

Great news to get the first patient recruited to the Sotrovimab prophylactic monoclonal arm of Protect-V and screening bloods smoothly through our lab 💪Immunology and Immunotherapy UHBRespResearch @Dr_D_Dosanjh

UHBRespResearch (@respresearchuhb) 's Twitter Profile Photo

Shannon Peters Banks Professor Alex Richter PROTECT-V Clinical Trial Immunology and Immunotherapy @Dr_D_Dosanjh You may be eligible if you are an adult who is immunocompeomised for whatever reason - main groups: those on dialysis, those with primary immunodeficiency, Hameonc or oncology patients on chemo or on immunosuppression for any reason eg organ transplant or autoimmune disease.

University Hospitals Birmingham (@uhbtrust) 's Twitter Profile Photo

We are delighted to support the #Sotrovimab arm of PROTECT-V Clinical Trial that launched yesterday for patient groups who are not able to mount a protective immune response to COVID-19 vaccination. Read more here 👉 bit.ly/3bE5CyK @Dr_D_Dosanjh UHB Research rona smith

We are delighted to support the #Sotrovimab arm of <a href="/PROTECT_CCTU/">PROTECT-V Clinical Trial</a> that launched yesterday for patient groups who are not able to mount a protective immune response to COVID-19 vaccination.

Read more here 👉 bit.ly/3bE5CyK
@Dr_D_Dosanjh <a href="/UHBResearch/">UHB Research</a> <a href="/RonaMarieSmith/">rona smith</a>
Birmingham Health Partners (@bhpcomms) 's Twitter Profile Photo

.University Hospitals Birmingham has begun roll-out of a drug trial which could prevent vulnerable & immunocompromised patients from catching #Covid19, particularly those who don't respond well to vaccinations. The #Sotrovimab arm of the PROTECT-V Clinical Trial is co-led by @Dr_D_Dosanjh birminghamhealthpartners.co.uk/preventative-c…

.<a href="/uhbtrust/">University Hospitals Birmingham</a> has begun roll-out of a drug trial which could prevent vulnerable &amp; immunocompromised patients from catching #Covid19, particularly those who don't respond well to vaccinations. The #Sotrovimab arm of the <a href="/PROTECT_CCTU/">PROTECT-V Clinical Trial</a> is co-led by @Dr_D_Dosanjh
birminghamhealthpartners.co.uk/preventative-c…
Alice Jasper (@_alicejasper) 's Twitter Profile Photo

Excited to be working on the PROTECT-V Clinical Trial clinical trial! Well done to everyone on the team who has started recruitment and thanks to all the volunteers who it wouldn't be possible without. #BePartOfResearch

University Hospitals Birmingham (@uhbtrust) 's Twitter Profile Photo

Andrew McKniff from Redditch has been one of the first participants to take part in the #Sotrovimab arm of the PROTECT-V Clinical Trial and received his dose yesterday at the Queen Elizabeth Hospital Birmingham. Read more here: bit.ly/3ArqKlG GSK @Dr_D_Dosanjh rona smith

Andrew McKniff from Redditch has been one of the first participants to take part in the #Sotrovimab arm of the <a href="/PROTECT_CCTU/">PROTECT-V Clinical Trial</a> and received his dose yesterday at the Queen Elizabeth Hospital Birmingham.

Read more here: bit.ly/3ArqKlG

<a href="/GSK/">GSK</a> @Dr_D_Dosanjh <a href="/RonaMarieSmith/">rona smith</a>
Cambridge University Hospitals NHS (@cuh_nhs) 's Twitter Profile Photo

📺 Tune into ITV News Anglia at 6.00pm today and BBC East at 6.30pm to see Dr Rona Smith and patient Julia Hulme being interviewed about the PROTECT-V trial and the ongoing fight against #Covid19. PROTECT-V Clinical Trial

📺  Tune into <a href="/itvanglia/">ITV News Anglia</a> at 6.00pm today and <a href="/BBCLookEast/">BBC East</a> at 6.30pm to see Dr Rona Smith and patient Julia Hulme being interviewed about the PROTECT-V trial and the ongoing fight against #Covid19.

<a href="/PROTECT_CCTU/">PROTECT-V Clinical Trial</a>
rona smith (@ronamariesmith) 's Twitter Profile Photo

@NIHR_Cam_CRF ITV News Anglia PROTECT-V Clinical Trial NIHR Cambridge Biomedical Research Centre Cambridge University Hospitals NHS Many thanks for highlighting the addition of sotrovimab to the PROTECT-V platform. Just a point of accuracy, Julia is receiving sotrovimab, not niclosamide, which was the first agent tested in this study